awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q42322534-C53035A8-F3ED-4EE4-ADF0-BB88F7F1215D
Q42322534-C53035A8-F3ED-4EE4-ADF0-BB88F7F1215D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42322534-C53035A8-F3ED-4EE4-ADF0-BB88F7F1215D
Circulating Tumor DNA Testing for Liver Cancer.
P2860
Q42322534-C53035A8-F3ED-4EE4-ADF0-BB88F7F1215D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42322534-C53035A8-F3ED-4EE4-ADF0-BB88F7F1215D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
635582bbe1bc31c07809c53aa5527bb28aa53642
P2860
A phase II study of the efficacy and safety of the combination therapy of the MEK inhibitor refametinib (BAY 86-9766) plus sorafenib for Asian patients with unresectable hepatocellular carcinoma.